Health Decisions Welcomes KLIXAR into the Agile Clinical Network
Health Decisions (Durham, NC) has a new company in its Agile Clinical Network, a community of research partners with the goal of higher efficiency standards in complex global studies.KLIXAR, an Argentinian CRO, has received certification after completing "rigorous" training in Agile Clinical development techniques.
“Our alliance with Health Decisions will enable us to broaden our customer base while providing unparalleled efficiency and transparency to pharmaceutical companies in Latin America,” said said Enrique Gaubeca, managing director at KLIXAR, in a company press release.
As part of the newly launched Network, KLIXAR will have access to Health Decisions’ data management systems, biostatistics expertise, medical writers, advanced data collection tools, and real-time reporting capabilities.
"We look forward to working with KLIXAR and all our Agile Clinical Network partners to raise the standards of efficiency for global clinical trials," said Rick Farris, COO at Health Decisions. "By producing rapid, accurate results for our sponsors regardless of geographic boundaries, we hope to shape the future of drug development..."
For more information about the Network, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
